ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,226Medicare Part D Prescriptions Filled, Including Refills

Rank: 327 out of 3734

$689K Total Retail Price of All Prescriptions

Rank: 327 out of 3734

407 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 407 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

31% of this provider’s 407 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 7,714 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
HYDROCODONE-ACETAMINOPHEN 816 402 S3 1 12
SIMVASTATIN 534 416 2 1
METOPROLOL TARTRATE 496 400 3 6
OMEPRAZOLE 384 236 4 4
LEVOTHYROXINE SODIUM 382 232 5 2
WARFARIN SODIUM 349 259 6 10
FUROSEMIDE 317 217 7 7
METFORMIN HCL 304 219 8 8
ZOLPIDEM TARTRATE 220 115 9 24
ENALAPRIL MALEATE 166 120 10 63
ATORVASTATIN CALCIUM 153 106 11 11
LISINOPRIL 148 95 12 3
CLOPIDOGREL 145 108 13 23
PANTOPRAZOLE SODIUM 144 117 14 22
GLYBURIDE 141 101 R 15 64
SERTRALINE HCL 131 111 16 18
DOXAZOSIN MESYLATE 123 84 17 100
FLUOXETINE HCL 110 19 18 61
PLAVIX 109 85 19 39
POTASSIUM CHLORIDE 107 61 20 19
GABAPENTIN 107 66 20 17
CARISOPRODOL 106 29 R 22 134
AZITHROMYCIN 100 52 23 38
PRAVASTATIN SODIUM 98 76 24 15
FAMOTIDINE 97 58 25 60
PAROXETINE HCL 93 49 26 59
ISOSORBIDE MONONITRATE ER 92 84 27 34
AMLODIPINE BESYLATE 89 70 28 5
QUINAPRIL HCL 89 68 28 74
LANSOPRAZOLE 88 59 30 155
SPIRIVA 87 49 31 40
HYDROCHLOROTHIAZIDE 85 49 32 9
AMOXICILLIN 84 48 33 108
TAMSULOSIN HCL 83 36 34 29
GLIMEPIRIDE 81 63 35 37
DIOVAN 79 43 36 31
DILTIAZEM 24HR ER 76 50 37 86
METOPROLOL SUCCINATE 74 49 38 14
VENTOLIN HFA 72 34 39 70
AMOX TR-POTASSIUM CLAVULANATE 72 42 39 164
MELOXICAM 71 38 41 52
SINGULAIR 70 20 42 95
RANITIDINE HCL 69 53 43 32
CYCLOBENZAPRINE HCL 69 0 R 43 87
DIGOXIN 67 67 45 43
TRICOR 65 50 46 93
NEXIUM 65 43 46 36
PREDNISONE 64 30 48 42
CYMBALTA 63 41 49 67
AMLODIPINE BESYLATE-BENAZEPRIL 62 53 50 56
ATENOLOL 62 51 50 13
AMITRIPTYLINE HCL 59 19 R 52 94
CIPROFLOXACIN HCL 58 37 53 77
DIOVAN HCT 58 30 53 72
TRAMADOL HCL 57 49 55 20
LANTUS 56 43 56 54
POLYETHYLENE GLYCOL 3350 56 35 56 53
ADVAIR DISKUS 56 37 56 35
INSULIN SYRINGE 55 40 59 109
CELEBREX 53 46 60 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 43 61 27
ESCITALOPRAM OXALATE 52 29 61 68
FINASTERIDE 51 51 63 88
DILTIAZEM 24HR CD 51 38 63 97
ZETIA 51 49 63 55
VERAPAMIL ER 50 38 66 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.